AstraZeneca AZN
$189.39 +$2.96 (+1.59%)
Pre-market · Nov 10, 7:30 am ET · After hours $189.39 0.00%
Open$189.36
Prev close$186.43
Day range$187.21 – $190.17
Volume2.43M
Market cap$293.73B
P/E (TTM)26.8
Dividend yield1.70%
AZN Stock News
Headlines matching AstraZeneca or the AZN ticker, most recent first.
- Citi Maintains AstraZeneca(AZN.US) With Buy Rating, Maintains Target Price $240.5
- AstraZeneca Wins U.S. Approval for Etcamah Combo to Tackle Endocrine‐Resistant Breast Cancer Positive
- Barclays Maintains AstraZeneca(AZN.US) With Buy Rating, Maintains Target Price $222.94
- Jefferies Maintains AstraZeneca(AZN.US) With Buy Rating, Maintains Target Price $236.45
- AstraZeneca Scores Minor Positive With U.S. Approval for Breast-Cancer Drug -- Market Talk Positive
- Berenberg Bank Maintains AstraZeneca(AZN.US) With Buy Rating, Maintains Target Price $215.74
- Deutsche Bank Maintains AstraZeneca(AZN.US) With Sell Rating, Cuts Target Price to $155.06 Negative
- J.P. Morgan Maintains AstraZeneca(AZN.US) With Buy Rating, Cuts Target Price to $215.74 Negative
- TD Cowen Maintains AstraZeneca(AZN.US) With Buy Rating, Announces Target Price $240
- J.P. Morgan Reaffirms Their Buy Rating on AstraZeneca (AZN)
- A Quick Look at Today's Ratings for AstraZeneca(AZN.US), With a Forecast Between $155.74 to $223.46
- A Quick Look at Today's Ratings for AstraZeneca(AZN.US), With a Forecast Between $155.78 to $241.13
- A Quick Look at Today's Ratings for AstraZeneca(AZN.US), With a Forecast Between $216.18 to $240.5
- A Quick Look at Today's Ratings for AstraZeneca(AZN.US), With a Forecast Between $191.8 to $267.19
- A Quick Look at Today's Ratings for AstraZeneca(AZN.US), With a Forecast Between $192.11 to $267.63
No comments yet — be the first to weigh in on AZN.
Sign in to join the discussion.